- 질문내용 -
I'd like to cancel a cheque emily joy delgra Shanghai Fosun Pharmaceutical Group surged the 10 percent limit in Shanghai, as well as 13.6 percentin Hong Kong, after its research and development subsidiaryChongqing Fochon entered a licensing agreement withSwitzerland's SELLAS Clinical for two chemical compounds.
|
|
